Effects of early steroid reduction in initial combination therapy for Kawasaki disease
Authors' conclusion
In cases in which the inflammatory response has been adequately controlled, it may be possible to taper steroid therapy faster than stated in previous studies without compromising treatment outcomes.
Study context
- Population
- Patients newly diagnosed with Kawasaki disease at high risk of intravenous immunoglobulin (IVIG) non-response, receiving initial steroid combination therapy with steroids reduced and discontinued over six days once inflammation controlled, June 2016–September 2023of 359 reviewed
- Participants
- 104 patients
- Outcome
- Recurrence of KD symptoms
Methodological detailssingle-centre
- Single-centre
Main finding
As reported in the abstract
Recurrence of Kawasaki disease (KD) symptoms, of 104 patients: 23
22.1%
Symptom recurrence after steroid tapering: 1
1.0%
Observational data: associations, not effects.
Further findings
Coronary artery lesions · One month after onset
- Coronary artery lesions, both small transient coronary artery aneurysms
- 2 (2.0%)
Original publication
Effects of early steroid reduction in initial combination therapy for Kawasaki disease. Rheumatology (Oxford). Published 1 March 2025. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →